Ingevity Corp (NGVT) › Cash & EquivalentsIngevity Corp (NGVT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $11.50M2014: $19.90M2015: $32.00M2016: $30.50M2017: $87.90M2018: $77.50M2019: $56.50M2020: $257.70M2021: $275.40M2022: $76.70M2023: $95.90M2024: $68.00M2025: $78.10M$78.10M2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$78.10M+14.9%2024$68.00M-29.1%2023$95.90M+25.0%2022$76.70M-72.1%2021$275.40M+6.9%2020$257.70M+356.1%2019$56.50M-27.1%2018$77.50M-11.8%2017$87.90M+188.2%2016$30.50M-4.7%2015$32.00M+60.8%2014$19.90M+73.0%2013$11.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share